2020/11
Palbociclib combined with endocrine therapy in heavily pretreated HR+/HER2- advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP). Breast. 2020 Nov 13;54:286-292. doi: 10.1016/j.breast.2020.11.005. Epub ahead of print. PMID: 33242755.F.I.:2.150.F.I.:2.150
Autores/as:
Manso L, Hernando C, Galán M, Oliveira M, Cabrera MA, Bratos R, Rodríguez CA, Ruiz-Borrego M, Blanch S, Llombart-Cussac A, Delgado-Mingorance JI, Álvarez-Busto I, Gallegos I, González-Cortijo L, Morales S, Aguirre E, Hernando BA, Ballesteros A, Alés-Martínez JE, Reboredo C, Oltra A, González-Cao M, Santisteban M, Malón D, Echeverría I, García-Garre E, Vega E, Se
Servicio:
Medicina Intensiva.- Complejo Hospitalario Universitario de Badajoz
Tipo:
Artículo
Materia: